Viewing Study NCT05392751

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-05-11 @ 5:16 PM
Study NCT ID: NCT05392751
Status: TERMINATED
Last Update Posted: 2024-10-15
First Post: 2022-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa
Sponsor: Endogena Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinitis Pigmentosa View
None Retinitis Pigmentosa Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RP View
None Retinitis Pigmentosa View
None EA-2353 View
None inherited retinal disease View
None IRD View